Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression
暂无分享,去创建一个
[1] Xian-Zhao Zhang,et al. MiR‐128‐3p accelerates cardiovascular calcification and insulin resistance through ISL1‐dependent Wnt pathway in type 2 diabetes mellitus rats , 2018, Journal of cellular physiology.
[2] N. Goodson,et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis , 2018, Arthritis Research & Therapy.
[3] D. Cook,et al. Association between depressive symptoms and objectively measured daily step count in individuals at high risk of cardiovascular disease in South London, UK: a cross-sectional study , 2018, BMJ Open.
[4] J. Trojanowski,et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases , 2017, Alzheimer's Research & Therapy.
[5] D. G. Zisoulis,et al. miR-128 inhibits telomerase activity by targeting TERT mRNA , 2017, bioRxiv.
[6] J. Park,et al. Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study , 2017, Diabetes & metabolism journal.
[7] O. Wolkowitz,et al. Leukocyte Telomere Length Predicts SSRI Response in Major Depressive Disorder: A Preliminary Report , 2016, Molecular Neuropsychiatry.
[8] Naveed Sattar,et al. The changing face of diabetes complications. , 2016, The lancet. Diabetes & endocrinology.
[9] B. Gangadhar,et al. Serum cortisol and BDNF in patients with major depression—effect of yoga , 2016, International review of psychiatry.
[10] Pao-Yen Lin,et al. Shortened telomere length in patients with depression: A meta-analytic study. , 2016, Journal of psychiatric research.
[11] Kathryn K. Ridout,et al. Depression and telomere length: A meta-analysis. , 2016, Journal of affective disorders.
[12] T. Riise,et al. Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms , 2015, International journal of endocrinology.
[13] Elizabeth A. Hoge,et al. Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls , 2015, Psychoneuroendocrinology.
[14] V. Mohan,et al. Circulating MiRNAs of ‘Asian Indian Phenotype’ Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes , 2015, PloS one.
[15] I. Hovatta. Genetics: Dynamic Cellular Aging Markers Associated with Major Depression , 2015, Current Biology.
[16] Warren W. Kretzschmar,et al. Molecular Signatures of Major Depression , 2015, Current Biology.
[17] Dragan M. Svrakic,et al. Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment , 2015, Drugs.
[18] Jian Shi. Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers , 2014, Acta Pharmacologica Sinica.
[19] F. Kronenberg,et al. Leucocyte Telomere Length and Risk of Type 2 Diabetes Mellitus: New Prospective Cohort Study and Literature-Based Meta-Analysis , 2014, PloS one.
[20] H. Thulesius,et al. Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes , 2014, BMC Endocrine Disorders.
[21] R. Ursano,et al. Telomere length - a cellular aging marker for depression and Post-traumatic Stress Disorder. , 2014, Medical hypotheses.
[22] E. Blackburn,et al. Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: The Strong Heart Family Study , 2014, Aging.
[23] M. de Groot,et al. Diabetes and Depression , 2014, Current Diabetes Reports.
[24] N. Saini,et al. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 , 2014, Molecular Cancer.
[25] E. Blackburn,et al. Short Leukocyte Telomere Length Predicts Risk of Diabetes in American Indians: the Strong Heart Family Study , 2013, Diabetes.
[26] K. Obrietan,et al. MicroRNA as therapeutic targets for treatment of depression , 2013, Neuropsychiatric disease and treatment.
[27] L. Milanesi,et al. Blood microRNA changes in depressed patients during antidepressant treatment , 2013, European Neuropsychopharmacology.
[28] L. Kunkel,et al. Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis , 2013, Journal of Cell Science.
[29] S. K. Aggarwal,et al. Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21 , 2013, Diabetes.
[30] V. Mohan,et al. Convergence of adipocyte hypertrophy, telomere shortening and hypoadiponectinemia in obese subjects and in patients with type 2 diabetes. , 2012, Clinical biochemistry.
[31] M. Sur,et al. The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders , 2012, Front. Psychiatry.
[32] R. Duman,et al. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents , 2012, Trends in Neurosciences.
[33] D. Segal,et al. The bidirectional relationship of depression and diabetes: a systematic review. , 2011, Clinical psychology review.
[34] V. Mohan,et al. Association of depression with complications of type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES- 102). , 2011, The Journal of the Association of Physicians of India.
[35] V. Mohan,et al. Prevalence of depression in relation to glucose intolerance in urban south Indians--the Chennai Urban Rural Epidemiology Study (CURES-76). , 2010, Diabetes technology & therapeutics.
[36] A. Bhansali,et al. Prevalence and determinants of depression in type 2 diabetes patients in a tertiary care centre. , 2010, The Indian journal of medical research.
[37] L. Almasy,et al. Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study. , 2010, Human molecular genetics.
[38] V. Mohan,et al. Prevalence of Depression in a Large Urban South Indian Population — The Chennai Urban Rural Epidemiology Study (Cures – 70) , 2009, PloS one.
[39] Guang Chen,et al. Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers , 2009, Neuropsychopharmacology.
[40] V. Mohan,et al. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. , 2007, Atherosclerosis.
[41] V. Mohan,et al. Telomere shortening & metabolic/vascular diseases. , 2007, The Indian journal of medical research.
[42] I. Chiodini,et al. Cortisol Secretion in Patients With Type 2 Diabetes , 2007, Diabetes Care.
[43] M. Suwa,et al. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. , 2006, Metabolism: clinical and experimental.
[44] V. Mohan,et al. Telomere shortening occurs in Asian Indian Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[45] L. Manni,et al. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. , 2005, International journal of cardiology.
[46] R. Cawthon. Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.
[47] K. Freedland,et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.
[48] M. Dimatteo,et al. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.
[49] P. Lacy,et al. Preliminary Studies on the Demonstration of Insulin in the Islets by the Fluorescent Antibody Technic , 1957, Diabetes.
[50] R. Sagar,et al. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: A randomized controlled trial. , 2018, Restorative neurology and neuroscience.
[51] V. Mohan,et al. Association of depression with common carotid artery intima media thickness and augmentation index in a large Urban South Indian population- The Chennai Urban Rural Epidemiology Study (CURES - 138) , 2015, Indian journal of endocrinology and metabolism.
[52] Yogesh K. Dwivedi. microRNAs as Biomarker in Depression Pathogenesis. , 2013, Annals of psychiatry and mental health.
[53] H. Gürvit,et al. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment. , 2013, Journal of Alzheimer's disease : JAD.
[54] V. Mohan,et al. Biomarkers of oxidative stress: methods and measures of oxidative DNA damage (COMET assay) and telomere shortening. , 2010, Methods in molecular biology.
[55] Y. Barde,et al. Physiology of the neurotrophins. , 1996, Annual review of neuroscience.